New York, March 3, 2026, 15:29 EST — Regular session
- RKLB was last up about 0.3% at $71.16, after an intraday swing of nearly 10%
- A Form 144 filing showed CEO Peter Beck plans to sell up to 28,761 shares, worth about $2.0 million
- Cantor Fitzgerald raised its price target to $85; other firms adjusted views after the Neutron timeline slipped
Rocket Lab Corporation shares swung sharply on Tuesday after founder and CEO Peter Beck filed paperwork to sell stock, and a broker raised its price target on the space company. The stock was last up 19 cents, about 0.3%, at $71.16 in afternoon trade, after ranging from $66.19 to $73.25. 1
The moves matter now because Rocket Lab has turned into a fast-twitch name for traders: defense contracts, space-systems growth and a delayed rocket program all tug the price in different directions.
Insider-sale notices can hit harder when a stock is already trading on timing risk. In Rocket Lab’s case, the next big driver is still execution — not another headline.
A Form 144 filing dated March 2 showed Beck as the person for whose account the securities are to be sold, with proposed sales totaling 28,761 common shares through Morgan Stanley Smith Barney’s executive services unit. The filing listed aggregate market value of about $2.0 million and said the shares were acquired through restricted stock vesting on March 1; it also showed no securities sold in the prior three months. 2
Form 144 is a notice of a proposed sale of restricted or “control” securities under SEC Rule 144. It does not guarantee a sale will happen, but it puts traders on alert for potential selling pressure.
Cantor Fitzgerald analyst Andres Sheppard raised the firm’s price target on Rocket Lab to $85 from $72 and kept an Overweight rating. He said the Geost acquisition “adds payloads as a new category of offering, and should position Rocket as a disruptive prime contractor for U.S. National Security Missions.” 3
Other analysts have been less uniform. Needham lowered its target to $95 due to the Neutron delay while maintaining a Buy rating, according to Investing.com. 4
Rocket Lab last week reported record annual revenue of $602 million and said it ended 2025 with a contracted backlog of $1.85 billion. Beck said the company “delivered record quarterly revenue of $180 million,” driving full-year revenue to a record $602 million. In the same release, Rocket Lab said Neutron’s first launch is now targeted for the fourth quarter of 2026 after a stage 1 tank test failure. 5
But the Neutron schedule remains the main risk factor for the stock. Further slips, or signs the program is getting more expensive, could undercut the bullish case even if near-term launches and space-systems work stay busy.
Traders will watch for follow-on filings that show whether the proposed sales actually hit the market, and for any fresh updates on Neutron testing milestones. Earnings calendars show Rocket Lab is expected to report next on May 7. 6
